- Home
- KRO vs RCKT Comparison
KRO vs RCKT Comparison
Compare KRO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- RCKT
- Stock Information
- Founded
- KRO 1916
- RCKT 1999
- Country
- KRO United States
- RCKT United States
- Employees
- KRO N/A
- RCKT N/A
- Industry
- KRO Major Chemicals
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- KRO Industrials
- RCKT Health Care
- Exchange
- KRO Nasdaq
- RCKT Nasdaq
- Market Cap
- KRO 803.0M
- RCKT 764.5M
- IPO Year
- KRO N/A
- RCKT N/A
- Fundamental
- Price
- KRO $6.78
- RCKT $6.77
- Analyst Decision
- KRO Hold
- RCKT Strong Buy
- Analyst Count
- KRO 3
- RCKT 11
- Target Price
- KRO $11.17
- RCKT $37.73
- AVG Volume (30 Days)
- KRO 278.0K
- RCKT 3.2M
- Earning Date
- KRO 05-07-2025
- RCKT 05-08-2025
- Dividend Yield
- KRO 2.84%
- RCKT N/A
- EPS Growth
- KRO N/A
- RCKT N/A
- EPS
- KRO 0.84
- RCKT N/A
- Revenue
- KRO $1,898,100,000.00
- RCKT N/A
- Revenue This Year
- KRO $13.24
- RCKT N/A
- Revenue Next Year
- KRO $7.35
- RCKT N/A
- P/E Ratio
- KRO $8.43
- RCKT N/A
- Revenue Growth
- KRO 10.42
- RCKT N/A
- 52 Week Low
- KRO $6.19
- RCKT $4.55
- 52 Week High
- KRO $14.50
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- KRO 38.30
- RCKT 48.68
- Support Level
- KRO $6.80
- RCKT $6.29
- Resistance Level
- KRO $7.11
- RCKT $6.89
- Average True Range (ATR)
- KRO 0.30
- RCKT 0.67
- MACD
- KRO -0.06
- RCKT -0.02
- Stochastic Oscillator
- KRO 1.32
- RCKT 41.34
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.